Rohto Pharmaceutical Co.,Ltd RPHCF Stock
Rohto Pharmaceutical Co.,Ltd Price Chart
Rohto Pharmaceutical Co.,Ltd RPHCF Financial and Trading Overview
| Rohto Pharmaceutical Co.,Ltd stock price | 15 USD |
| Previous Close | 15 USD |
| Open | 15.2 USD |
| Bid | 13.5 USD x 40000 |
| Ask | 16.1 USD x 40000 |
| Day's Range | 15.2 - 15.2 USD |
| 52 Week Range | 14.34 - 16.3 USD |
| Volume | 150 USD |
| Avg. Volume | 2 USD |
| Market Cap | 3.43B USD |
| Beta (5Y Monthly) | -0.457 |
| PE Ratio (TTM) | 16.703297 |
| EPS (TTM) | 0.9 USD |
| Forward Dividend & Yield | 0.32 (2.12%) |
| Ex-Dividend Date | September 30, 2026 |
| 1y Target Est | N/A |
RPHCF Valuation Measures
| Enterprise Value | -4836535808 USD |
| Trailing P/E | 16.703297 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.009992456 |
| Price/Book (mrq) | 1.8354188 |
| Enterprise Value/Revenue | -0.014 |
| Enterprise Value/EBITDA | -0.083 |
Trading Information
Rohto Pharmaceutical Co.,Ltd Stock Price History
| Beta (5Y Monthly) | -0.457 |
| 52-Week Change | 1.90% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 16.3 USD |
| 52 Week Low | 14.34 USD |
| 50-Day Moving Average | 15.09 USD |
| 200-Day Moving Average | 15.41 USD |
RPHCF Share Statistics
| Avg. Volume (3 month) | 2 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 225.96M |
| Float | 200.75M |
| Short Ratio | N/A |
| % Held by Insiders | 9.69% |
| % Held by Institutions | 36.05% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 46 |
| Trailing Annual Dividend Yield | 306.66% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.4749 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2026 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | March 31, 2027 |
Profitability
| Profit Margin | 9.96% |
| Operating Margin (ttm) | 8.24% |
| Gross Margin | 56.06% |
| EBITDA Margin | 16.89% |
Management Effectiveness
| Return on Assets (ttm) | 5.60% |
| Return on Equity (ttm) | 11.63% |
Income Statement
| Revenue (ttm) | 343.73B USD |
| Revenue Per Share (ttm) | 1521.15 USD |
| Quarterly Revenue Growth (yoy) | 9.59% |
| Gross Profit (ttm) | 192.69B USD |
| EBITDA | 58.09B USD |
| Net Income Avi to Common (ttm) | 34.25B USD |
| Diluted EPS (ttm) | 0.91 |
| Quarterly Earnings Growth (yoy) | -3.69% |
Balance Sheet
| Total Cash (mrq) | 86.82B USD |
| Total Cash Per Share (mrq) | 384.2 USD |
| Total Debt (mrq) | 60.24B USD |
| Total Debt/Equity (mrq) | 18.82 USD |
| Current Ratio (mrq) | 2.039 |
| Book Value Per Share (mrq) | 8.281488 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 47.79B USD |
| Levered Free Cash Flow (ttm) | 9.06B USD |
Profile of Rohto Pharmaceutical Co.,Ltd
| Country | United States |
| State | N/A |
| City | Osaka |
| Address | 1-8-1 Tatsuminishi |
| ZIP | 544-8666 |
| Phone | 81 6 6758 1231 |
| Website | https://www.rohto.co.jp |
| Industry | Household & Personal Products |
| Sector(s) | Consumer Defensive |
| Full Time Employees | N/A |
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. The company was founded in 1899 and is headquartered in Osaka, Japan.
Q&A For Rohto Pharmaceutical Co.,Ltd Stock
What is a current RPHCF stock price?
Rohto Pharmaceutical Co.,Ltd RPHCF stock price today per share is 15 USD.
How to purchase Rohto Pharmaceutical Co.,Ltd stock?
You can buy RPHCF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Rohto Pharmaceutical Co.,Ltd?
The stock symbol or ticker of Rohto Pharmaceutical Co.,Ltd is RPHCF.
Which industry does the Rohto Pharmaceutical Co.,Ltd company belong to?
The Rohto Pharmaceutical Co.,Ltd industry is Household & Personal Products.
How many shares does Rohto Pharmaceutical Co.,Ltd have in circulation?
The max supply of Rohto Pharmaceutical Co.,Ltd shares is 225.96M.
What is Rohto Pharmaceutical Co.,Ltd Price to Earnings Ratio (PE Ratio)?
Rohto Pharmaceutical Co.,Ltd PE Ratio is 16.66666800 now.
What was Rohto Pharmaceutical Co.,Ltd earnings per share over the trailing 12 months (TTM)?
Rohto Pharmaceutical Co.,Ltd EPS is 0.9 USD over the trailing 12 months.
Which sector does the Rohto Pharmaceutical Co.,Ltd company belong to?
The Rohto Pharmaceutical Co.,Ltd sector is Consumer Defensive.